OCT4

OCT4 Protein

Score: 0.360 Price: $0.36 Undruggable Druggability Status: active
HYPOTHESES
1
PAPERS
23
KG EDGES
0
DEBATES
0

3D Protein Structure

🧬 OCT4 — PDB 3L1P Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

Druggability & Clinical Context

Druggability
Undruggable
Score: 0.23
Clinical Stage
Preclinical
Target Class
Protein
Safety
0.50
Druggability Analysis
Drug Development0.00
Structural Tractability0.30
Target Class0.50
Safety Profile0.50
Key Metrics
PDB Structures:
0
Known Drugs:
1
Approved:
0
In Clinical Trials:
0
Drug Pipeline (1 compounds)
1 Preclinical
Mechanism: Prioritized from 1 SciDEX hypotheses, including: Partial Neuronal Reprogramming via Modified Yamanaka Cocktail
Drug Pipeline (1 compounds)
1 Preclinical
Known Drugs:
CHEMBL5797734 (preclinical)
Structural Data:
PDB —AlphaFold ✓Cryo-EM —
UniProt: Q01860

🧬 3D Protein Structure

🧬 OCT4 — PDB 3L1P Click to expand interactive 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll

3D Protein Structure (AlphaFold)

Open full viewer

AlphaFold predicted structure available for Q01860

View AlphaFold Structure

Linked Hypotheses (1)

Partial Neuronal Reprogramming via Modified Yamanaka Cocktail0.672

Linked Experiments (0)

No linked experiments

Scoring Dimensions

Portfolio 0.00 (25%) Druggability 0.23 (20%) Evidence 1.00 (20%) Safety 0.50 (15%) Competitive 0.40 (10%) Connectivity 0.00 (10%) 0.360 composite

Knowledge Graph (20)

activates (8)

OCT4cellular_reprogrammingOCT4POU5F1OCT4SOX2OCT4KLF4OCT4DNMT3A
▸ Show 3 more
OCT4PluripotencyPOU5F1OCT4KLF4OCT4

biomarker for (5)

OCT4MYCOCT4SOX2OCT4KLF4MYCOCT4KLF4OCT4

implicated in (1)

OCT4neurodegeneration

interacts with (1)

OCT4SOX2

involved in (1)

OCT4Self-Renewal

regulates (2)

OCT4SOX2OCT4KLF4

targets (1)

h-baba5269OCT4

therapeutic target (1)

OCT4neurodegeneration

Debate History (0)

No debates yet